2.8(top 20%)
impact factor
1.9K(top 10%)
papers
59.1K(top 5%)
citations
99(top 5%)
h-index
3.0(top 20%)
extended IF
2.0K
all documents
63.9K
doc citations
136(top 10%)
g-index
Top Articles
| # | Title | Journal | Year | Citations |
|---|---|---|---|---|
| 1 | The 2008 WHO classification of lymphomas: implications for clinical practice and translational research | Hematology American Society of Hematology Education Program | 2009 | 484 |
| 2 | Relapsed/Refractory Diffuse Large B-Cell Lymphoma | Hematology American Society of Hematology Education Program | 2011 | 386 |
| 3 | Hemophagocytic lymphohistiocytosis (HLH) and related disorders | Hematology American Society of Hematology Education Program | 2009 | 307 |
| 4 | Update on Cobalamin, Folate, and Homocysteine | Hematology American Society of Hematology Education Program | 2003 | 299 |
| 5 | Recent Advances in Thrombotic Thrombocytopenic Purpura | Hematology American Society of Hematology Education Program | 2004 | 259 |
| 6 | Clinical Use of Intravenous Iron: Administration, Efficacy, and Safety | Hematology American Society of Hematology Education Program | 2010 | 248 |
| 7 | Hemophagocytic lymphohistiocytosis: pathogenesis and treatment | Hematology American Society of Hematology Education Program | 2013 | 238 |
| 8 | The Role of Platelets in Atherothrombosis | Hematology American Society of Hematology Education Program | 2011 | 231 |
| 9 | Bacterial Contamination of Blood Components: Risks, Strategies, and Regulation | Hematology American Society of Hematology Education Program | 2003 | 222 |
| 10 | The Molecular Basis of Leukemia | Hematology American Society of Hematology Education Program | 2004 | 217 |
| 11 | Drug-induced thrombocytopenia: pathogenesis, evaluation, and management | Hematology American Society of Hematology Education Program | 2009 | 213 |
| 12 | FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? | Hematology American Society of Hematology Education Program | 2013 | 204 |
| 13 | Evidence-Based Platelet Transfusion Guidelines | Hematology American Society of Hematology Education Program | 2007 | 203 |
| 14 | Recognizing and Managing Chronic Graft-Versus-Host Disease | Hematology American Society of Hematology Education Program | 2008 | 195 |
| 15 | Pros and cons of new oral anticoagulants | Hematology American Society of Hematology Education Program | 2013 | 195 |
| 16 | The Hematologist and Radiation Casualties | Hematology American Society of Hematology Education Program | 2003 | 194 |
| 17 | T-cell acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2016 | 194 |
| 18 | FLT3 Mutations: Biology and Treatment | Hematology American Society of Hematology Education Program | 2006 | 193 |
| 19 | Secondary Iron Overload | Hematology American Society of Hematology Education Program | 2001 | 189 |
| 20 | Diffuse large B-cell lymphoma: R-CHOP failure—what to do? | Hematology American Society of Hematology Education Program | 2016 | 189 |
| 21 | Stem Cell Mobilization | Hematology American Society of Hematology Education Program | 2003 | 188 |
| 22 | Iron overload in thalassemia: different organs at different rates | Hematology American Society of Hematology Education Program | 2017 | 186 |
| 23 | Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes | Hematology American Society of Hematology Education Program | 2007 | 178 |
| 24 | Drug-induced immune hemolytic anemia | Hematology American Society of Hematology Education Program | 2009 | 176 |
| 25 | Malaria, erythrocytic infection, and anemia | Hematology American Society of Hematology Education Program | 2009 | 175 |
| 26 | Cytokine release syndrome with novel therapeutics for acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2016 | 173 |
| 27 | Hepcidin and Its Role in Regulating Systemic Iron Metabolism | Hematology American Society of Hematology Education Program | 2006 | 171 |
| 28 | The role of NOTCH1 signaling in T-ALL | Hematology American Society of Hematology Education Program | 2009 | 171 |
| 29 | The post-thrombotic syndrome | Hematology American Society of Hematology Education Program | 2016 | 171 |
| 30 | Hypercoagulability in Sickle Cell Disease: New Approaches to an Old Problem | Hematology American Society of Hematology Education Program | 2007 | 170 |
| 31 | Current concepts in the pathophysiology and treatment of aplastic anemia | Hematology American Society of Hematology Education Program | 2013 | 169 |
| 32 | Approach to Hemophagocytic Syndromes | Hematology American Society of Hematology Education Program | 2011 | 165 |
| 33 | How to approach thrombocytopenia | Hematology American Society of Hematology Education Program | 2012 | 162 |
| 34 | Familial and Acquired Hemophagocytic Lymphohistiocytosis | Hematology American Society of Hematology Education Program | 2005 | 161 |
| 35 | The molecular genetic makeup of acute lymphoblastic leukemia | Hematology American Society of Hematology Education Program | 2012 | 161 |
| 36 | Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance | Hematology American Society of Hematology Education Program | 2009 | 157 |
| 37 | Nurture versus Nature: The Microenvironment in Chronic Lymphocytic Leukemia | Hematology American Society of Hematology Education Program | 2011 | 157 |
| 38 | Stem Cells: Hype and Reality | Hematology American Society of Hematology Education Program | 2002 | 156 |
| 39 | Atypical Cellular Disorders | Hematology American Society of Hematology Education Program | 2004 | 155 |
| 40 | Mutations in AML: prognostic and therapeutic implications | Hematology American Society of Hematology Education Program | 2016 | 155 |
| 41 | Iron Deficiency and Overload | Hematology American Society of Hematology Education Program | 2003 | 154 |
| 42 | Dendrimer-based nanoparticles for cancer therapy | Hematology American Society of Hematology Education Program | 2009 | 153 |
| 43 | Minimal Residual Disease in Acute Lymphoblastic Leukemia | Hematology American Society of Hematology Education Program | 2010 | 152 |
| 44 | Venous Thrombosis: The Role of Genes, Environment, and Behavior | Hematology American Society of Hematology Education Program | 2005 | 150 |
| 45 | AL amyloidosis: from molecular mechanisms to targeted therapies | Hematology American Society of Hematology Education Program | 2017 | 150 |
| 46 | Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia | Hematology American Society of Hematology Education Program | 2008 | 149 |
| 47 | Independent prognostic factors for AML outcome | Hematology American Society of Hematology Education Program | 2009 | 148 |
| 48 | Hb H disease: clinical course and disease modifiers | Hematology American Society of Hematology Education Program | 2009 | 147 |
| 49 | Central venous catheter–related thrombosis | Hematology American Society of Hematology Education Program | 2014 | 147 |
| 50 | The many faces of common variable immunodeficiency | Hematology American Society of Hematology Education Program | 2012 | 146 |